Table 2.
Model 1: β (95% CI, P) | Model 2: β (95% CI, P) | Model 3: β (95% CI, P) | |
---|---|---|---|
Non-NAFLD | Reference | Reference | Reference |
NAFLD | 0.048 (0.025, 0.071) .00006 |
0.016 (–0.003, 0.035) .10899 |
0.012 (–0.015, 0.039) .39327 |
Males | |||
Non-NAFLD | Reference | Reference | Reference |
NAFLD | 0.062 (0.030, 0.095) .00021 |
0.008 (–0.017, 0.033) .51872 |
0.011 (–0.028, 0.049) .59332 |
Females | |||
Non-NAFLD | Reference | Reference | Reference |
NAFLD | 0.011 (–0.023, 0.046) .51859 |
0.008 (–0.022, 0.039) .58534 |
–0.021 (–0.068, 0.026) .38129 |
HbA1c = glycated hemoglobin, HDL = high-density lipoprotein, LDL = low-density lipoprotein, NAFLD = nonalcoholic fatty liver disease.
Model 1: No covariates were adjusted. Model 2: Age, gender, race were adjusted.
Model 3: Age, gender, race, body mass index, poverty to income ratio, diabetes status, waist circumference, HbA1c (%), total cholesterol, LDL-cholesterol, HDL-cholesterol, ALT, ALP, GGT, AST, serum iron, total bone mineral density, CAP and LSM were adjusted. In the subgroup analysis stratified by gender or race, the model is not adjusted for the stratification variable itself.